Endometriosis (EMs) is one of the most prevalent benign gynaecological diseases, and it is an inflammatory oestrogen-dependent condition. Several authors have proposed that anatomical, genetic, endocrine, immunological, environmental, hormonal, and inflammatory factors may influence tissue implantation outside the uterus. An approach to EMs aetiology that involves defining a profile to the vaginal and gut microbiota, estrogenic activity, and exposure to xenoestrogens and also metabolic and nutritional status of women with EMs may help identify some important patterns to better characterize this disease and also to define more personalized nutritional strategies, also predicting patients' predisposition to therapy success. This is an observational study on premenopausal woman, diagnosed with EMs, who will be recruited on the outpatient gynaecology appointment, to evaluate the vaginal and intestinal microbiome, measure the total estrogenic activity, assess the metabolic biomarkers and the nutritional status.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Vaginal microbiome
Timeframe: day 1
Intestinal microbiome
Timeframe: day 1
Strogen levels
Timeframe: day 1
Fasting blood glucose
Timeframe: day 1
Insulin
Timeframe: day 1
Total cholesterol
Timeframe: day 1
HDL cholesterol
Timeframe: day 1
LDL cholesterol
Timeframe: day 1
25-hydroxy vitamin D
Timeframe: day 1
Ascorbic acid
Timeframe: day 1
Alpha (α)-tocopherol
Timeframe: day 1
Omega-3 index
Timeframe: day 1